3,525
Views
27
CrossRef citations to date
0
Altmetric
Drug Evaluation

Selumetinib for the treatment of cancer

, MD MSCI & , MD

Figures & data

Box 1. Drug summary.

Table 1. Selected Phase II clinical trials of selumetinib in advanced gastrointestinal cancer patients.

Table 2. Selected Phase II clinical trials of selumetinib in thyroid cancer, NSCLC, AML and ovarian cancer.

Table 3. Selected Phase II clinical trials of selumetinib in advanced melanoma patients.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.